Canadian Cancer Trials Group:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Canadian Cancer Trials Group - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C12319
◆発行会社(調査会社):GlobalData
◆発行日:2018年12月
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Canadian Cancer Trials Group (CCTG), is a subsidiary of Cancer Research Institute at Queen’s University, is a contract research organization that conducts clinical trials. The company conducts trials for the development of new drugs and therapies for the treatment of various diseases. It provides services for cancer therapy, supportive care and prevention. CCTG offers clinical trials for products such as gemcitabine, oxaliplatin, cetuximab, brivanib alaninate, BBI608 and leucovorin, among others. The company provides services for diseases related to brain, breast, gastro-intestinal, genito-urinary, gynecologic, head and neck, hematologic, lung, melanoma, sarcoma and symptom control. It operates through its campus located in Ontario. NCIC Clinical is headquartered in Kingston, Ontario, Canada.

Canadian Cancer Trials Group – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Canadian Cancer Trials Group, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Canadian Cancer Trials Group, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Canadian Cancer Trials Group, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Canadian Cancer Trials Group, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Canadian Cancer Trials Group, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Canadian Cancer Trials Group, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Cancer Research Enters into Agreement with Canadian Cancer Trials 10
Senhwa Biosciences Enters into Agreement with Canadian Cancer Trials 11
Xbiotech Enters into Agreement with NCIC Clinical Trials 12
Contextual Genomics Enters into Research Collaboration with NCIC Clinical Trials Group 13
Canadian Cancer Trials Group – Key Competitors 14
Canadian Cancer Trials Group – Key Employees 15
Canadian Cancer Trials Group – Locations And Subsidiaries 16
Head Office 16
Recent Developments 17
Government and Public Interest 17
May 01, 2017: Canadian Cancer Trials Group awarded $23.5M over 5 years 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
Canadian Cancer Trials Group, Pharmaceuticals & Healthcare, Key Facts 2
Canadian Cancer Trials Group, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Canadian Cancer Trials Group, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Canadian Cancer Trials Group, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Canadian Cancer Trials Group, Deals By Therapy Area, 2012 to YTD 2018 8
Canadian Cancer Trials Group, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Cancer Research Enters into Agreement with Canadian Cancer Trials 10
Senhwa Biosciences Enters into Agreement with Canadian Cancer Trials 11
Xbiotech Enters into Agreement with NCIC Clinical Trials 12
Contextual Genomics Enters into Research Collaboration with NCIC Clinical Trials Group 13
Canadian Cancer Trials Group, Key Competitors 14
Canadian Cancer Trials Group, Key Employees 15

List of Figures
Canadian Cancer Trials Group, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Canadian Cancer Trials Group, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Canadian Cancer Trials Group, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Canadian Cancer Trials Group, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Canadian Cancer Trials Group, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Canadian Cancer Trials Group, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Canadian Cancer Trials Group, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Canadian Cancer Trials Group, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Canadian Cancer Trials Group:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Strike Resources Ltd (SRK):企業の財務・戦略的SWOT分析
    Summary Strike Resources Ltd (Strike Resources) is a mining and mineral exploration and development company. The company explores for uranium, coal, and iron ore. Strike Resources’ projects portfolio includes Cusco Iron Ore project, Burke Graphite Project, Solaroz Lithium Brine Project, Pilbara Lith …
  • Travis Perkins Plc (TPK):企業の財務・戦略的SWOT分析
    Travis Perkins Plc (TPK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • iX Biopharma Ltd (42C):企業の財務・戦略的SWOT分析
    Summary iX Biopharma Ltd (iX Biopharma) is a pharmaceutical company that provides that offers drug delivery and formulation. The company's pipeline product portfolio includes development of drugs for various indications such as opioid-sparing for acute, severe and chronic pain; male erectile dysfunc …
  • Lululemon Athletica, Inc. (LULU):企業の財務・戦略的SWOT分析
    Lululemon Athletica, Inc. (LULU) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • 3M India Limited (3MINDIA):企業の財務・戦略的SWOT分析
    3M India Limited (3MINDIA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Hibbett Sports Inc:企業の戦略・SWOT・財務分析
    Hibbett Sports Inc - Strategy, SWOT and Corporate Finance Report Summary Hibbett Sports Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Handok Inc (002390):医療機器:M&Aディール及び事業提携情報
    Summary Handok Inc (Handok), formerly Handok Pharmaceuticals Co Ltd is a pharmaceutical and health care company that manufactures, develops, and distributes healthcare solutions. The company develops and provides pharmaceutical products such as OTC drugs, medical devices, prescription drugs and in v …
  • ConforMIS Inc (CFMS):企業の財務・戦略的SWOT分析
    Summary ConforMIS Inc (ConforMIS) is a medical technology company that manufactures, develops, and markets joint replacement implants. The company’s knee replacement implant products include iTotal CR a cruciate-retaining product, iTotal PS a posterior cruciate ligament substituting product, and iDu …
  • Imperial College London-医療機器分野:企業M&A・提携分析
    Summary Imperial College London (Imperial) is a research university that offers educational services. The university provides undergraduate and postgraduate courses. It offers courses in the field of science and technology, agriculture, business, the humanities, and medicine. It conducts clinical tr …
  • Emera Inc (EMA):企業の財務・戦略的SWOT分析
    Emera Inc (EMA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Spanish National Cancer Research Center-製薬・医療分野:企業M&A・提携分析
    Summary Spanish National Cancer Research Center (CNIO) is a medical research center that offers cancer research programs. The center is an integral cancer research institute which integrates basic and translational cancer research. It conducts various scientific programs which include molecular onco …
  • Lund University-製薬・医療分野:企業M&A・提携分析
    Summary Lund University (LNU) is an educational service provider that offers master and bachelor programmes. It offers education and research in the areas of engineering, economics and management, science, law, social sciences, medicine, humanities, theology, fine art, music and others. The universi …
  • 3M Company:企業のM&A・事業提携・投資動向
    3M Company - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's 3M Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capi …
  • Kitov Pharmaceuticals Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Kitov Pharmaceuticals Ltd (Kitov Pharmaceuticals) a subsidiary of Kitov Pharma Ltd, is a biopharmaceutical company with focus on drug development. Its pipeline therapeutic candidates include Consensi, a combination drug with celecoxib and amlodipine besylate as active ingredients for the tre …
  • Microsemi Corp:企業の戦略的SWOT分析
    Microsemi Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Cineworld Group Plc:企業の戦略・SWOT・財務分析
    Cineworld Group Plc - Strategy, SWOT and Corporate Finance Report Summary Cineworld Group Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Scilex Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析
    Summary Scilex Pharmaceuticals Inc (Scilex Pharma), a subsidiary of Sorrento Therapeutics Inc is a developer of pharmaceutical products. The company develops and commercializes branded pharmaceutical products for the treatment of pain. Its technologies include drug delivery and proprietary patch tec …
  • Novo Nordisk A/S:企業のM&A・事業提携・投資動向
    Novo Nordisk A/S - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Novo Nordisk A/S Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), dives …
  • TriMas Corporation:企業のM&A・事業提携・投資動向
    TriMas Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's TriMas Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), d …
  • Oncology Venture ApS:製薬・医療:M&Aディール及び事業提携情報
    Summary Oncology Venture ApS (Oncology Venture), a subsidiary of Oncology Venture Sweden AB, is a developer of oncology products. The company offers products in the therapeutic areas of metastatic breast cancer, ovarian cancer, renal cancer, liver cancer, prostate cancer, multiple myeloma, and other …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆